Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The biological consequences of altered MHC class I expression in tumours.

Journal of biological regulators and homeostatic agents - 1 Jan 2000

Algarra I, Gaforio J J, Cabrera T, Collado A, Garrido F

Abstract excerpt

The identification of different mechanisms by which tumours escape from the immune system has helped to evaluate the clinical relevance of a variety of phenotypic changes that occur during tumour development. Among them, changes in HLA class I expression play a leading role in the tumour-host environment since HLA class I molecules interact with T lymphocytes for antigen presentation and with NK cells for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Histocompatibility Antigens Class I
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasms

Share to Phenotype

Share to Reference Values

Source

Identifiers

PMID: 10503731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The biological consequences of altered MHC class I expression in tumours.PMID 10503731Read ↗

Tumour immunology, vaccination and escape strategies.Semantic proximity Read ↗

The HLA crossroad in tumor immunology.Semantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

Altered MHC class I antigens in tumors.Semantic proximity Read ↗

Cancer immune escape: MHC expression in primary tumours versus metastasesSemantic proximity Read ↗

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.Semantic proximity Read ↗

Role of altered expression of HLA class I molecules in cancer progression.Semantic proximity Read ↗

Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implicationsSemantic proximity Read ↗

Different mechanisms can lead to the same altered HLA class I phenotype in tumors.Semantic proximity Read ↗

Targeting HLA class I expression to increase tumor immunogenicitySemantic proximity Read ↗

Deregulation of HLA-I in cancer and its central importance for immunotherapySemantic proximity Read ↗

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.